Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Telephone
Email address available at https://www.ox.ac.uk/gsearch

Websites

Sherlock Group | Immunobiology of Systemic Rheumatic Disease
Principal Investigator, Kennedy Institute

Jonathan Sherlock

Honorary Senior Clinical Research Fellow

Recent publications

The critical role of interleukin-23 in spondyloarthropathy

Sherlock J. et al, (2017), Molecular immunology, 57, 38 - 43

Spondyloarthropathy: interleukin 23 and disease modification.

Sherlock JP. et al, (2015), Lancet, 385, 2017 - 2018

The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases

Sherlock JP. et al, (2015), Current Opinion in Rheumatology, 27, 71 - 75

The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases.

Sherlock JP. et al, (2015), Curr Opin Rheumatol, 27, 71 - 75

The critical role of interleukin-23 in spondyloarthropathy.

Sherlock JP. et al, (2014), Mol Immunol, 57, 38 - 43

More publications